Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates

September 20, 2024

Sponsored By

Are generalist investors good or bad for biotech? How did Elaine and Adam's trip to New York go? And how long has George Church owned that brown corduroy blazer?

We cover all that and more on the latest episode of "The Readout Loud." Mizuho analyst Jared Holz joins us to discuss what the Federal Reserve's long-awaited decision to lower interest rates means for biotech stocks and startups. Elaine, Adam, and Allison also discuss the latest news in life sciences, including the use of cannabinoid receptor drugs in weight loss and the Lasker Awards, a.k.a. "America's Nobel."

Listen Now

For more on Novo Nordisk and Corbus Pharmaceuticals' CB1 work, go here; for more on the Lasker Award recipients, click here; for more on Applied Therapeutics' cancelled Food and Drug Administration meeting, click here; and to learn more about George Church's new startup, go here.